✦ LIBER ✦

817 RANDOMISED CONTROLLED TRIAL OF 24 AND 48 WEEKS OF PEGYLATED INTERFERON alfa 2a PLUS RIBAVIRIN IN PATIENTS WITH GENOTYPE 3 HCV AND CIRRHOSIS

✍ Scribed by Foster, G.; Shoeb, D.; Weatherall, A.; Moreea, S.; Vilar, J.; Freshwater, D.; Ryder, S.; Alexander, G.; Forton, D.; Mills, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[10] THE SAFETY AND EFFICACY OF TARIBAVI

✍ P. Marcellin; Y. Lurie; M. Rodrigues-Torres; R. Chasen; Y. Xu; B. Murphy 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 117 KB

1416 FALDAPREVIR PLUS PEGYLATED INTERFER

✍ Ferenci, P.; Asselah, T.; Foster, G.R.; Zeuzem, S.; Sarrazin, C.; Moreno, C.; Ou 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

2005 VIROLOGIC RESPONSE RATES FOLLOWING

✍ Jacobson, I.; Pockros, P.J.; Lalezari, J.; Lawitz, E.; Rodriguez-Torres, M.; DeJ 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A randomised controlled trial on pegylat

✍ A. Mangia; G.L. Ricci; N. Minerva; M. Persico; V. Carretta; D. Bacca; M. Cela; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Simeprevir with pegylated interferon alf

✍ Jacobson, Ira M; Dore, Gregory J; Foster, Graham R; Fried, Michael W; Radu, Moni 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 284 KB

1221 Rate of sustained virologic respons

✍ CHEINQUER, H; COELHOBORGES, S; CHEINQUER, N 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB